(Q34228210)

31 July 2017

title

Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins (English)

1 reference

31 July 2017

Haoming Xu

4

0 references

Robert J. Linhardt

8

object named as

Robert J Linhardt

1 reference

31 July 2017

9

Jian Liu

1 reference

31 July 2017

Yongmei Xu

1

1 reference

31 July 2017

Sayaka Masuko

2

1 reference

31 July 2017

Majde Takieddin

3

1 reference

31 July 2017

Renpeng Liu

5

1 reference

31 July 2017

Juliana Jing

6

1 reference

31 July 2017

Shaker A Mousa

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

334

1 reference

31 July 2017

issue

6055

1 reference

31 July 2017

page(s)

498-501

1 reference

Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

First oral warfarin alternative approved in the US.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Chemoenzymatic Design of Heparan Sulfate Oligosaccharides*

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

In vivo models for the evaluation of antithrombotics and thrombolytics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

In vitro methods of evaluating antithrombotics and thrombolytics.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Potential of new anticoagulants in patients with cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Design of biologically active heparan sulfate and heparin using an enzyme-based approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Lessons learned from the contamination of heparin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Solution structures of chemoenzymatically synthesized heparin and its precursors.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Triggers, targets and treatments for thrombosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Engineering sulfotransferases to modify heparan sulfate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Beyond unfractionated heparin and warfarin: current and future advances

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Chemoenzymatic synthesis with distinct Pasteurella heparosan synthases: monodisperse polymers and unnatural structures.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Beyond heparin and warfarin: the new generation of anticoagulants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Anticoagulant heparan sulfate: structural specificity and biosynthesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Determination of the substrate specificities of N-acetyl-d-glucosaminyltransferase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Enzymatic redesigning of biologically active heparan sulfate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Regulated diversity of heparan sulfate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Isolation and characterization of human heparin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3425363

Anti-Xa and anti-IIa drugs alter international normalized ratio measurements: potential problems in the monitoring of oral anticoagulants

5 July 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

Generation of "neoheparin" from E. coli K5 capsular polysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1207478

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1207478

1 reference

31 July 2017

1 reference

31 July 2017

1 reference